Nizatidine is a gastric acid secretion inhibitor developed by the Lilai Company in the United States. It was first sold in the United States in 1987 and is named Axid. Nizatidine is a powerful H2 receptor antagonist. Acts on gastric acid-secreting cells to block gastric acid formation and reduce basic gastric acid. It also suppresses […]
